title: Oral administration of an HSP90 inhibitor, 17-DMAG, intervenes tumor-cell infiltration into multiple organs and improves survival period for ATL model mice.
abstract: In the peripheral blood leukocytes (PBLs) from the carriers of the human T-lymphotropic virus type-1 (HTLV-1) or the patients with adult T-cell leukemia (ATL), nuclear factor kappaB (NF-κB)-mediated antiapoptotic signals are constitutively activated primarily by the HTLV-1-encoded oncoprotein Tax. Tax interacts with the I κB kinase regulatory subunit NEMO (NF-κB essential modulator) to activate NF-κB, and this interaction is maintained in part by a molecular chaperone, heat-shock protein 90 (HSP90), and its co-chaperone cell division cycle 37 (CDC37). The antibiotic geldanamycin (GA) inhibits HSP90's ATP binding for its proper interaction with client proteins. Administration of a novel water-soluble and less toxic GA derivative, 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride (17-DMAG), to Tax-expressing ATL-transformed cell lines, C8166 and MT4, induced significant degradation of Tax. 17-DMAG also facilitated growth arrest and cellular apoptosis to C8166 and MT4 and other ATL cell lines, although this treatment has no apparent effects on normal PBLs. 17-DMAG also downregulated Tax-mediated intracellular signals including the activation of NF-κB, activator protein 1 or HTLV-1 long terminal repeat in Tax-transfected HEK293 cells. Oral administration of 17-DMAG to ATL model mice xenografted with lymphomatous transgenic Lck-Tax (Lck proximal promoter-driven Tax transgene) cells or HTLV-1-producing tumor cells dramatically attenuated aggressive infiltration into multiple organs, inhibited de novo viral production and improved survival period. These observations identified 17-DMAG as a promising candidate for the prevention of ATL progression.
authors: Department of Infectious Diseases, Faculty of Medicine, Oita University, Yufu, Japan.
authors: E
authors: E
authors: Ikebe
authors: A
authors: A
authors: Kawaguchi
authors: K
authors: K
authors: Tezuka
authors: S
authors: S
authors: Taguchi
authors: S
authors: S
authors: Hirose
authors: T
authors: T
authors: Matsumoto
authors: T
authors: T
authors: Mitsui
authors: K
authors: K
authors: Senba
authors: A
authors: A
authors: Nishizono
authors: M
authors: M
authors: Hori
authors: H
authors: H
authors: Hasegawa
authors: Y
authors: Y
authors: Yamada
authors: T
authors: T
authors: Ueno
authors: Y
authors: Y
authors: Tanaka
authors: H
authors: H
authors: Sawa
authors: W
authors: W
authors: Hall
authors: Y
authors: Y
authors: Minami
authors: K T
authors: KT
authors: Jeang
authors: M
authors: M
authors: Ogata
authors: K
authors: K
authors: Morishita
authors: H
authors: H
authors: Hasegawa
authors: J
authors: J
authors: Fujisawa
authors: H
authors: H
authors: Iha
references: Science. 1999 Apr 9;284(5412):321-5
references: 10195897
references: J Biol Chem. 2002 Nov 22;277(47):45306-14
references: 12226087
references: Oncogene. 1999 Jul 22;18(29):4182-90
references: 10435631
references: Science. 1999 Apr 9;284(5412):313-6
references: 10195895
references: J Biol Chem. 2003 May 30;278(22):19642-8
references: 12657630
references: J Biol Chem. 1998 Aug 7;273(32):20090-5
references: 9685350
references: Virology. 1991 Mar;181(1):218-27
references: 1899734
references: J Biol Chem. 2001 Feb 9;276(6):4494-500
references: 11080499
references: Front Biosci. 2007 Jan 01;12:1496-507
references: 17127397
references: Nat Rev Mol Cell Biol. 2011 Dec 14;13(1):7-12
references: 22166994
references: Nat Med. 2006 Apr;12(4):466-72
references: 16550188
references: Cell. 2008 Feb 8;132(3):344-62
references: 18267068
references: Leukemia. 2009 Nov;23(11):2090-101
references: 19710698
references: Cell Death Differ. 2006 May;13(5):773-84
references: 16410802
references: Trends Cell Biol. 2007 Feb;17(2):87-92
references: 17184992
references: J Immunol. 2008 Jul 1;181(1):629-40
references: 18566430
references: Trends Biochem Sci. 2006 Mar;31(3):164-72
references: 16483782
references: Mol Cell Biol. 1994 Feb;14(2):1459-64
references: 8289821
references: Virology. 2009 Nov 10;394(1):64-72
references: 19744686
references: Cold Spring Harb Perspect Biol. 2009 Nov;1(5):a000141
references: 20066113
references: Cell. 2004 Jan 9;116(1):87-98
references: 14718169
references: Int J Cancer. 2012 May 15;130(10):2318-26
references: 21780105
references: Cell. 1997 Jul 11;90(1):65-75
references: 9230303
references: Blood. 2010 Jul 8;116(1):45-53
references: 20351313
references: Autophagy. 2007 Nov-Dec;3(6):600-3
references: 17671417
references: J Clin Exp Hematop. 2010;50(1):9-25
references: 20505272
references: Annu Rev Immunol. 2001;19:475-96
references: 11244044
references: Nat Cell Biol. 2004 Feb;6(2):97-105
references: 14743216
references: Mol Cell. 2003 Mar;11(3):647-58
references: 12667448
references: Annu Rev Cell Dev Biol. 2011;27:107-32
references: 21801009
references: J Clin Oncol. 2010 Mar 20;28(9):1591-8
references: 20177026
references: J Biol Chem. 1998 Jun 26;273(26):15891-4
references: 9632633
references: FEBS J. 2005 Sep;272(18):4684-90
references: 16156789
references: Blood. 2006 Feb 1;107(3):1092-100
references: 16234364
references: Cell. 1998 Jun 26;93(7):1231-40
references: 9657155
references: Mol Cell Biol. 2006 May;26(9):3378-89
references: 16611982
references: Mol Cell. 2002 Feb;9(2):401-10
references: 11864612
references: Nat Rev Cancer. 2007 Apr;7(4):270-80
references: 17384582
references: Mol Cell. 2000 Jun;5(6):981-92
references: 10911992
references: Leuk Lymphoma. 1999 Dec;36(1-2):15-23
references: 10613446
references: Cancer Chemother Pharmacol. 2002 Jan;49(1):7-19
references: 11855755
references: Genes Dev. 1999 May 15;13(10):1322-8
references: 10346820
references: J Biol Chem. 1999 Jun 18;274(25):17402-5
references: 10364167
references: Cell. 1998 Apr 3;93(1):81-91
references: 9546394
references: J Virol. 2004 Nov;78(21):11823-32
references: 15479824
references: Oncogene. 2005 Sep 5;24(39):5965-75
references: 16155603
references: Mol Cell Biol. 1998 Sep;18(9):5157-65
references: 9710600
references: Oncogene. 2005 Sep 5;24(39):6058-68
references: 16155612
references: J Virol. 2004 Nov;78(21):11686-95
references: 15479810
references: Mol Cell Biol. 2005 Dec;25(23):10391-406
references: 16287853
references: Blood. 2009 Oct 1;114(14):2961-8
references: 19657116
references: Oncogene. 2003 Dec 4;22(55):8912-23
references: 14654787
references: Nat Rev Immunol. 2002 Oct;2(10):725-34
references: 12360211